XML 18 R6.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Condensed Consolidated Statements of Shareholders’ Deficit - USD ($)
$ in Thousands
Total
Shareholders’ Deficit attributable to the Company
Treasury Stock
Paid-in 
Capital
Accumulated 
Deficit
NCI
Members Units
Class A Common Stock
Class A Common Stock
Common Stock
Class B Common Stock
Class B Common Stock
Common Stock
Class C Common Stock
Class C Common Stock
Common Stock
Beginning balance, members units (shares) at Dec. 31, 2022             122,505,500            
Beginning balance (in shares) at Dec. 31, 2022                 0   0   0
Beginning balance, members units at Dec. 31, 2022             $ 1            
Beginning balance at Dec. 31, 2022 $ (57,619)   $ 0 $ 14,967 $ (72,587)       $ 0   $ 0   $ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Cumulative preferred dividends (328)                        
Net loss - pre-business combination (5,751)                        
Establishment of redeemable noncontrolling interest (85,865)                        
Net income attributable to the Company (9,360)                        
Ending balance, members units (shares) at Mar. 31, 2023             0            
Ending balance (in shares) at Mar. 31, 2023                 16,021,804   10,566   68,140,188
Ending balance, members units at Mar. 31, 2023             $ 0            
Ending balance at Mar. 31, 2023 (883,328)   (12,825) 0 (870,511)       $ 2   $ 0   $ 6
Beginning balance, members units (shares) at Dec. 31, 2022             122,505,500            
Beginning balance (in shares) at Dec. 31, 2022                 0   0   0
Beginning balance, members units at Dec. 31, 2022             $ 1            
Beginning balance at Dec. 31, 2022 (57,619)   0 14,967 (72,587)       $ 0   $ 0   $ 0
Ending balance (in shares) at Dec. 31, 2023               20,987,988 22,279,876 0   70,909,012 70,909,012
Ending balance, NCI at Dec. 31, 2023 (263,282) $ (263,282) (12,825) 0 (250,466) $ 0     $ 2       $ 7
Ending balance at Dec. 31, 2023 (263,282)                        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Share-based compensation expense 3,926 3,926   3,926                  
Cumulative preferred dividends (471) (471)   (471)                  
Accretion of preferred stock discount (8) (8)   (8)                  
Conversion of Series A preferred stock (Note 7) (in shares)                 7,738,743        
Conversion of Series A preferred stock (Note 7) 23,120 23,120   23,119         $ 1        
Net loss - pre-business combination 0                        
Issuance of stock (in shares)                 3,487,278        
Issuance of stock $ 0                        
Class A common stock issued for stock options exercised (in shares) 167,985               167,402        
Class A common stock issued for stock options exercised $ 0                        
Transaction costs (24,400)                        
Class A common stock issued for warrants exercised (in shares)                 18,823,633        
Class A common stock issued for warrants exercised 126,212 126,212   126,210         $ 2        
Subsequent remeasurement of redeemable noncontrolling interests (284,810) (284,810)   (152,776) (132,034)                
Net income attributable to noncontrolling interest 972         972              
Net income attributable to the Company (98,337) (98,337)     (98,337)                
Ending balance (in shares) at Mar. 31, 2024               51,246,932 52,496,932 0   70,909,012 70,909,012
Ending balance, NCI at Mar. 31, 2024 (492,678) $ (493,650) $ (12,825) $ 0 $ (480,837) $ 972     $ 5       $ 7
Ending balance at Mar. 31, 2024 $ (493,650)